July 25, 2023, Chicago, Ill… The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess the risk of adult cardiac surgery operations.

Jul 25, 2023
career development
Understand and embrace a hospital's decision-making process to get the products you need to perform at your best.
4 min read
Elisabeth Dexter, MD

Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. The GORE® TAG® Thoracic Branch Endoprosthesis (TBE) is single-branch aortic stent graft that provides an off-the-shelf solution for patients that need zone II aortic coverage and obviates the need for prior left subclavian revascularization. The Thoraflex Hybrid Frozen Elephant Trunk (FET) device is a pre-mated surgical graft and an aortic stent graft to facilitate single-stage treatment of arch and proximal descending aortic pathologies.

1 hr. 7 min.
Career Development Blog
As an early career surgeon, you don’t want to be left on an island without the backing of your partners and department leaders., Robert M. Van Haren, MD, MsPH
3 min read
Robert M. Van Haren, MD, MsPH

Cardiothoracic surgeons from the US and Italy receive practice-changing funding support

CHICAGO (January 19, 2022)—Through a collaborative effort between The Society of Thoracic Surgeons (STS) and the European Association for Cardio-Thoracic Surgery (EACTS), two standout young surgeons recently each received $20,000 in fellowship grants to learn new techniques used by institutions across the world.

Jan 19, 2022

Longtime society efforts advance connecting clinical outcomes and claims data 

WASHINGTON, DC (October 21, 2021) — The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) applaud Representatives Larry Bucshon, MD (R-IN), and Kim Schrier, MD (D-WA), for introducing the Meaningful Access to Federal Health Plan Claims Data Act of 2021.

Oct 21, 2021

The 2021 C. Walton Lillehei Lecture was presented during The Society of Thoracic Surgeons 57th Annual Meeting by Paul G. Yock, MD, MA, founder and director of the Stanford Byers Center for Biodesign in California.

During the lecture, Dr. Yock encourage participants to view innovation as a discipline—one that can be taught, practiced, and recreated. He acknowledged, though, that comprehensive innovation can be difficult in the health care setting because it involves multiple stakeholders. He likened the “user” in this scenario to an “eight-headed monster.”

While social media engagements may seem fleeting, the authors agreed that durable scholarly impact of social media exists.
31 min.
They talk about how they got started in robotic surgery, the importance of institutional support for building and training a team, and the efficacy of robotic surgery as an instructional tool for residents and fellows.
1 hr. 3 min.

Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve. Arman Kilic, MD, and Ara A. Vaporciyan, MD, along with medical student Brian Ayers, discuss what AI and ML mean, how it can uncover previously unknown relationships in medical data, and how it can be used to assist the surgeon in the operating room.